Lannett Co Inc (LCI): Price and Financial Metrics
GET POWR RATINGS... FREE!
LCI Stock Summary
- LCI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.41 -- higher than just 3.61% of US-listed equities with positive expected earnings growth.
- With a price/sales ratio of 0.09, LANNETT CO INC has a higher such ratio than only 1.46% of stocks in our set.
- LCI's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.38% of US stocks.
- If you're looking for stocks that are quantitatively similar to LANNETT CO INC, a group of peers worth examining would be AGFS, TEVA, FLNT, PTPI, and PAAS.
- LCI's SEC filings can be seen here. And to visit LANNETT CO INC's official web site, go to www.lannett.com.
LCI Valuation Summary
- LCI's EV/EBIT ratio is -3.2; this is 131.53% lower than that of the median Healthcare stock.
- LCI's price/earnings ratio has moved down 34.7 over the prior 243 months.
Below are key valuation metrics over time for LCI.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
LCI | 2023-01-30 | 0.1 | -0.1 | -0.1 | -3.2 |
LCI | 2023-01-27 | 0.1 | -0.1 | -0.1 | -3.2 |
LCI | 2023-01-26 | 0.1 | -0.1 | -0.1 | -3.2 |
LCI | 2023-01-25 | 0.1 | -0.1 | -0.1 | -3.2 |
LCI | 2023-01-24 | 0.1 | -0.1 | -0.1 | -3.2 |
LCI | 2023-01-23 | 0.1 | -0.1 | -0.1 | -3.2 |
LCI Growth Metrics
- Its 2 year net income to common stockholders growth rate is now at -911.84%.
- Its 5 year cash and equivalents growth rate is now at -23.16%.
- The 4 year price growth rate now stands at -64.74%.

The table below shows LCI's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 314.133 | -35.653 | -237.297 |
2022-06-30 | 340.579 | -7.125 | -231.62 |
2022-03-31 | 372.399 | 38.531 | -316.211 |
2021-12-31 | 406.412 | 99.284 | -288.455 |
2021-09-30 | 453.824 | 90.275 | -379.318 |
2021-06-30 | 478.778 | 60.851 | -363.475 |
LCI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- LCI has a Quality Grade of C, ranking ahead of 38.22% of graded US stocks.
- LCI's asset turnover comes in at 0.579 -- ranking 62nd of 682 Pharmaceutical Products stocks.
- AWH, DRRX, and CLSN are the stocks whose asset turnover ratios are most correlated with LCI.
The table below shows LCI's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.579 | 0.146 | -0.243 |
2021-06-30 | 0.535 | 0.158 | -0.227 |
2021-03-31 | 0.507 | 0.181 | -0.193 |
2020-12-31 | 0.502 | 0.199 | -0.198 |
2020-09-30 | 0.473 | 0.272 | 0.008 |
2020-06-30 | 0.470 | 0.303 | 0.016 |
LCI Price Target
For more insight on analysts targets of LCI, see our LCI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $6.00 | Average Broker Recommendation | 2 (Hold) |
LCI Stock Price Chart Interactive Chart >
LCI Price/Volume Stats
Current price | $0.67 | 52-week high | $1.19 |
Prev. close | $0.68 | 52-week low | $0.39 |
Day low | $0.65 | Volume | 722,300 |
Day high | $0.77 | Avg. volume | 389,317 |
50-day MA | $0.61 | Dividend yield | N/A |
200-day MA | $0.56 | Market Cap | 28.24M |
Lannett Co Inc (LCI) Company Bio
Lannett Company develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.
Latest LCI News From Around the Web
Below are the latest news stories about LANNETT CO INC that investors may wish to consider to help them evaluate LCI as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! |
Lannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call TranscriptLannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call Transcript February 1, 2023 Operator: Greetings and welcome to the Lannett Company Fiscal 2023 Second Quarter Financial Results Conference Call. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Robert Jaffe, Investor Relations for Lannett Company. […] |
Lannett (LCI) Reports Q2 Loss, Tops Revenue EstimatesLannett (LCI) delivered earnings and revenue surprises of 17.07% and 10.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCELannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2023 second quarter ended December 31, 2022. |
LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITLannett Company, Inc. (NYSE: LCI) today announced that its Board of Directors approved a 1-for-4 reverse stock split of its issued and outstanding shares of common stock, effective at 5 p.m. Eastern Time on February 6, 2023. Beginning February 7, 2023, the company's common stock will trade on a split-adjusted basis. The common stock will continue to trade on the New York Stock Exchange (NYSE) under the symbol "LCI," but will trade under the new CUSIP number 516012 200. The reverse stock split wa |
LCI Price Returns
1-mo | 18.42% |
3-mo | 34.62% |
6-mo | 18.06% |
1-year | -30.93% |
3-year | -92.25% |
5-year | -96.62% |
YTD | 28.65% |
2022 | -67.85% |
2021 | -75.15% |
2020 | -26.08% |
2019 | 77.82% |
2018 | -78.62% |
Continue Researching LCI
Want to see what other sources are saying about Lannett Co Inc's financials and stock price? Try the links below:Lannett Co Inc (LCI) Stock Price | Nasdaq
Lannett Co Inc (LCI) Stock Quote, History and News - Yahoo Finance
Lannett Co Inc (LCI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...